Lung Cancer

Disparities in Lung Cancer Screening Eligibility Still Exist

Findings seen despite the U.S. Preventive Services Task Force revised eligibility criteria Despite increases in lung cancer screening eligibility, gender, racial, and ethnic screening disparities may still persist, according to a study published online Jan. 12 in JAMA Network Open. Thomas J. Reese, Pharm.D., Ph.D., from the University of Utah in Salt Lake City, and colleagues...

When Cancer Strikes Those Under 40, Race Matters

Young Black and Hispanic cancer patients face poorer survival odds than their white counterparts, even from some cancers that are highly curable, a new study finds. It’s well known that the United States has long-standing racial disparities in cancer survival. The researchers said the new findings bolster evidence that those disparities are not confined to...

Segregation, Poverty Tied to Worse Outcomes for Black Lung Cancer Patients

Racial segregation may help explain why Black Americans with lung cancer do more poorly than their white counterparts, a new study suggests. For years, U.S. studies have documented racial disparities in lung cancer. Black Americans are less likely to receive surgery for early-stage lung cancer — the standard of care — and they typically die...

Residential Segregation May Worsen NSCLC Outcomes for Black Patients

Blacks more likely to present at advanced stage, less likely to receive surgery, have higher mortality at higher residential segregation levels. Black patients are more likely to present with advanced non-small cell lung cancer (NSCLC) and are less likely to receive surgery at higher residential segregation levels, according to a study presented at the annual...

As Medicaid Access Expands, So Does Cancer Survival

More lower-income Americans are surviving cancer due to expanded Medicaid health care coverage, a new study shows. Researchers found a link between long-term survival of patients newly diagnosed with cancer — across all stages and types of the disease — and expanded Medicaid income eligibility. In other words, survival odds improved in states that granted...

Immunotherapy Drug Can Beat Back Early-Stage Lung Cancer

An immunotherapy drug is the first to significantly reduce the risk of cancer recurrence or death in people with early-stage lung cancer, researchers report. Atezolizumab reduced by 34% the risk of disease recurrence or death in a certain group of people with stage II to IIIA non-small cell lung cancer — those whose tumors carry...

As Medicaid Access Expands, So Does Cancer Survival

More lower-income Americans are surviving cancer due to expanded Medicaid health care coverage, a new study shows. Researchers found a link between long-term survival of patients newly diagnosed with cancer — across all stages and types of the disease — and expanded Medicaid income eligibility. In other words, survival odds improved in states that granted...

Care No Better for Minority Cancer Patients With Medicaid Expansion

No change in receipt of definitive care reported for minorities in expansion states versus nonexpansion states. For patients with cancer, Medicaid expansion is not associated with improved care at minority-serving hospitals (MSHs), according to a study published online May 11 in JCO Oncology Practice. David-Dan Nguyen, M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues...

Disparities in Early Stage Cancer Treatments

Reports continually highlight the disparities between Black and white Americans in completing treatment for curable lung cancer and breast cancer. Disproportionately, African Americans are less likely to complete treatment, resulting in a higher rate of deaths. Researchers designed a quality improvement trial to examine potential interventions. Using data from 2007 to 2012, the researchers established...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.